Title : Hinokitiol, a tropolone derivative, inhibits mouse melanoma (B16-F10) cell migration and in vivo tumor formation.

Pub. Date : 2015 Jan 5

PMID : 25449038






8 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Hinokitiol appeared to achieve this effect by reducing the expression of MMP-1 and by suppressing the phosphorylation of mitogen- activated protein kinase (MAPK) signaling molecules such as extracellular signal-regulated kinase (ERK) 1/2, p38 MAPK and c-Jun N-terminal kinases (JNK). beta-thujaplicin matrix metallopeptidase 13 Mus musculus
2 Hinokitiol appeared to achieve this effect by reducing the expression of MMP-1 and by suppressing the phosphorylation of mitogen- activated protein kinase (MAPK) signaling molecules such as extracellular signal-regulated kinase (ERK) 1/2, p38 MAPK and c-Jun N-terminal kinases (JNK). beta-thujaplicin mitogen-activated protein kinase 1 Mus musculus
3 Hinokitiol appeared to achieve this effect by reducing the expression of MMP-1 and by suppressing the phosphorylation of mitogen- activated protein kinase (MAPK) signaling molecules such as extracellular signal-regulated kinase (ERK) 1/2, p38 MAPK and c-Jun N-terminal kinases (JNK). beta-thujaplicin mitogen-activated protein kinase 3 Mus musculus
4 Hinokitiol appeared to achieve this effect by reducing the expression of MMP-1 and by suppressing the phosphorylation of mitogen- activated protein kinase (MAPK) signaling molecules such as extracellular signal-regulated kinase (ERK) 1/2, p38 MAPK and c-Jun N-terminal kinases (JNK). beta-thujaplicin mitogen-activated protein kinase 14 Mus musculus
5 Hinokitiol appeared to achieve this effect by reducing the expression of MMP-1 and by suppressing the phosphorylation of mitogen- activated protein kinase (MAPK) signaling molecules such as extracellular signal-regulated kinase (ERK) 1/2, p38 MAPK and c-Jun N-terminal kinases (JNK). beta-thujaplicin jun proto-oncogene Mus musculus
6 On the other hand, hinokitiol treatment reversed IkappaB-alpha degradation and inhibited the phosphorylation of p65 nuclear factor kappa B (NF-kappaB) and cJun in B16-F10 cells. beta-thujaplicin nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha Mus musculus
7 On the other hand, hinokitiol treatment reversed IkappaB-alpha degradation and inhibited the phosphorylation of p65 nuclear factor kappa B (NF-kappaB) and cJun in B16-F10 cells. beta-thujaplicin jun proto-oncogene Mus musculus
8 In addition, hinokitiol suppressed the translocation of p65 NF-kappaB from the cytosol to the nucleus, suggesting reduced NF-kappaB activation. beta-thujaplicin v-rel reticuloendotheliosis viral oncogene homolog A (avian) Mus musculus